Search research articles
Contact Us
Filters
Showing results (381-390 of 390) with videos related to
Page
of 39
Sort By:
You have reached the last page of results.
This site can display upto 390 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 30, 2024
Effects of Compound Probiotics on Pharmacokinetics of Cytochrome 450 Probe Drugs in Rats
Yanjuan Zhang, Zhi Chen, Yayi Xiao, et al.
Nature Genetics
|
June 17, 2022
Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease
Hongbo Liu, Tomohito Doke, Dong Guo, et al.
Oncology Reports
|
November 9, 2017
Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation
Yi-Ming Cao, Jun Gu, Yan-Shu Zhang, et al.
HGG Advances
|
August 20, 2025
Genetic rare disease prevention and control: Family-based screening and reproductive interventions in Changsha
Ge Lin, Jun He, Yuankun Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 26, 2014
OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin
Ligong Chen, Yan Shu, Xiaomin Liang, et al.
International Journal of Cancer
|
April 18, 2014
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial
Feng-Cai Zhu, Wen Chen, Yue-Mei Hu, et al.
Molecular Oncology
|
April 14, 2023
RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
Jiesi Zhou, Yan Shu Kong, Krista M Vincent, et al.
Pharmacological Reviews
|
March 2, 2006
PharmGKB submission update: V. PMT submissions of genetic variation in SLC22 family transporters
Yan Shu, Thomas J Urban, Maya K Leabman, et al.
Cancer Medicine
|
July 16, 2019
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial
Feng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Cancer Medicine
|
December 21, 2016
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial
Feng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Page
of 39
Search research articles
Search
Showing results (381-390 of 390) with videos related to
Sort By:
Page
of 39
You have reached the last page of results.
This site can display upto 390 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 30, 2024
Effects of Compound Probiotics on Pharmacokinetics of Cytochrome 450 Probe Drugs in Rats
Yanjuan Zhang, Zhi Chen, Yayi Xiao, et al.
Nature Genetics
|
June 17, 2022
Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease
Hongbo Liu, Tomohito Doke, Dong Guo, et al.
Oncology Reports
|
November 9, 2017
Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation
Yi-Ming Cao, Jun Gu, Yan-Shu Zhang, et al.
HGG Advances
|
August 20, 2025
Genetic rare disease prevention and control: Family-based screening and reproductive interventions in Changsha
Ge Lin, Jun He, Yuankun Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 26, 2014
OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin
Ligong Chen, Yan Shu, Xiaomin Liang, et al.
International Journal of Cancer
|
April 18, 2014
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial
Feng-Cai Zhu, Wen Chen, Yue-Mei Hu, et al.
Molecular Oncology
|
April 14, 2023
RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
Jiesi Zhou, Yan Shu Kong, Krista M Vincent, et al.
Pharmacological Reviews
|
March 2, 2006
PharmGKB submission update: V. PMT submissions of genetic variation in SLC22 family transporters
Yan Shu, Thomas J Urban, Maya K Leabman, et al.
Cancer Medicine
|
July 16, 2019
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial
Feng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Cancer Medicine
|
December 21, 2016
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial
Feng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Page
of 39